Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.

Inclusion Criteria:

• Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension;
• logMAR visual acuity not worse than 0.6.

Exclusion Criteria:

• Clinically relevant ophthalmic or systemic conditions may be excluded.